drugset / Trial / NCT05098041
A Study of Soticlestat and Rifampin in Healthy Adults
NaSequentialOpen-labelBasic science
Summary
The main aim of this study is to check how rifampin affects the way soticlestat is processed by the body. Participants will be required to stay at the study clinic for 18 consecutive days. On the first full day and 15th day, participants will take a single dose of soticlestat. Rifampin will be taken each day starting on the 5th day for 13 consecutive days. Clinic staff will follow up with each participant about 15 days after the last soticlestat dose to check for any side effects.
Timeline
- Start
- 2021-11-22
- Primary completion
- 2022-02-16
- Completion
- 2022-03-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rifampin | Small molecule | 600 mg | Oral |
| Subject | Soticlestat | Small molecule | 300 mg | Oral |
Indications
No indication recorded.